COMPANY
Centinel Spine
Timeline
- Trial start —: Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices source ↗
- FDA FDA 510(k) clearance: prodisc® L Instruments — K250554, Apr 25, 2025. Applicant at approval: Centinel Spine, LLC. source ↗
- FDA FDA 510(k) clearance: prodisc® L Instruments — K242869, Dec 17, 2024. Applicant at approval: Centinel Spine, LLC. source ↗
- Trial start —: Retrospective Study With Patients Treated With STALIF® C or M and Ti or FLX Implants for 1 and 2 Levels source ↗
- Trial start Not phased (device or behavioral study): 2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C source ↗
Upcoming milestones
- 2030-12 (ESTIMATED) · · Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices · NCT07370493
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07370493 | Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices | Not listed | Enrolling by invitation | Nov 1, 2025 | 2030-12 (estimated) |
| NCT04012996 | 2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C | Not phased (device or behavioral study) | Active, not recruiting | Aug 5, 2019 | Aug 31, 2025 (estimated) |
| NCT05610397 | Retrospective Study With Patients Treated With STALIF® C or M and Ti or FLX Implants for 1 and 2 Levels | Not listed | Unknown status (ClinicalTrials.gov) | Apr 24, 2023 | Apr 30, 2024 (estimated) |
FDA records (last 2 years)
Connect
See your connections at Centinel Spine on LinkedIn (search by name, results not checked)